A phase III randomized trial comparing adjuvant concomitant chemoradiotherapy versus standard adjuvant chemotherapy followed by radiotherapy in operable node-positive breast cancer: Final results

International Journal of Radiation Oncology Biology Physics

Volumn 64, Issue 4, 2006, Pages 1072-1080

  Rouëssé, Jacques ^a   De La Lande, Brigitte ^a   Bertheault Cvitkovic, Frédérique ^a   Serin, Daniel ^b   Graïc, Yvon ^c   Combe, Martin ^d   Leduc, Bernard ^d   Lucas, Virginie ^e   Demange, Liliane ^f   Nguyen, Tan Dat ^f   Castèra, Daniel ^g   Krzisch, Claude ^h   Villet, Richard ⁱ   Mouret Fourme, Emmanuelle ^a   Garbay, Jean Rémy ^a   Noguès, Catherine ^a   Alberini ^a   Becette ^a   Belichard ^a   Bensaoula, ^a   Bertrand, ^a   Bethune Volters ^a   Bieche ^a   Boudinet, ^a   Bourguignat, ^a   Brain, ^a   Breton Callu, ^a   Briffod, ^a   Callet, ^a   Cherel ^a   Cohen Solal, ^a   Corone, ^a   Costes, ^a   Cothier Savey, ^a   Cvitkovic, ^a   De La Lande, ^a   De Maulmont, ^a   Ferrero Pous ^a   Floiras, ^a   Foucault, ^a   Fourme, ^a   Gardillou, ^a   Goupil, ^a   Guinebretiere ^a   Hagay, ^a   Janvier, ^a   Labib, ^a   Lasry, ^a   Lerebours, ^a   Lidereau, ^a   Marx, ^a   Mefti, ^a   Menet, ^a   Mignot, ^a   Moisson, ^a   Nogues ^a   Oglobine, ^a   Ouhioun, ^a   Pallud, ^a   Pecking, ^a   Petot, ^a   Pichon, ^a   Plantet, ^a   Pratili, ^a   Renody, ^a   Rimareix, ^a   Rodier, ^a   Rouesse ^a   Spyratos, ^a   Stevens, ^a   Talma, ^a   Trassard, ^a   Tubiana, ^a   Turpin, ^a   Yacoub, ^a   more..

^a CENTRE RENÉ HUGUENIN   (France)

^b INSTITUT SAINTE CATHERINE   (France)

^c CENTRE HENRI BECQUEREL   (France)

^d CENTRE HOSPITALIER   (France)

^e CENTRE HOSPITALIER RÉGIONAL D ORLÉANS   (France)

^f Institut Godinot   (France)

^g Clinique Saint Pierre   (France)

^h AMIENS UNIVERSITY HOSPITAL   (France)

ⁱ Hopital des Diaconesses   (France)

Author keywords

Adjuvant chemotherapy; Breast cancer; Chemoradiotherapy; Radiotherapy

Indexed keywords

ADJUVANT CHEMOTHERAPY; BREAST CANCER; CHEMORADIOTHERAPY;

BIOLOGICAL ORGANS; ONCOLOGY; RADIOTHERAPY; TOXICITY; TUMORS;

CHEMOTHERAPY;

ANTIEMETIC AGENT; CYCLOPHOSPHAMIDE; EPIRUBICIN; FLUOROURACIL; MITOXANTRONE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ACUTE TOXICITY; ADULT; ALOPECIA; ANEMIA; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER RELAPSE; CANCER SURGERY; CANCER SURVIVAL; CARDIOTOXICITY; CHEMOTHERAPY INDUCED EMESIS; CHRONOTHERAPY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DISEASE SEVERITY; ENDOMETRIUM CANCER; FEBRILE NEUTROPENIA; FEMALE; HUMAN; INTERMETHOD COMPARISON; KIDNEY CANCER; LEUKOPENIA; LUNG CANCER; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; LYMPHEDEMA; MAJOR CLINICAL STUDY; MASTECTOMY; MULTICENTER STUDY; MULTIMODALITY CANCER THERAPY; MULTIVARIATE ANALYSIS; NAUSEA AND VOMITING; PARTIAL MASTECTOMY; PHASE 3 CLINICAL TRIAL; PIGMENT DISORDER; PRIORITY JOURNAL; PROGNOSIS; RADIATION DOSE; RADIATION RESPONSE; RANDOMIZED CONTROLLED TRIAL; RECURRENCE RISK; SECOND CANCER; SIGMOID CARCINOMA; SKIN TOXICITY; TELANGIECTASIA; THYROID CANCER; TREATMENT DURATION; UTERINE CERVIX CANCER;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; CONFIDENCE INTERVALS; CYCLOPHOSPHAMIDE; DISEASE-FREE SURVIVAL; DRUG ADMINISTRATION SCHEDULE; EPIRUBICIN; FEMALE; FLUOROURACIL; HUMANS; MIDDLE AGED; MITOXANTRONE; NEOPLASM RECURRENCE, LOCAL; NEOPLASMS, SECOND PRIMARY; RADIOTHERAPY, ADJUVANT;

EID: 33644539268     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2005.10.011     Document Type: Article

References (47)

1. G. Bonadonna, P. Valagussa, A. Moliterni Adjuvant cyclophosphamide, methotrexate, and fluorouracil in node-positive breast cancer, the results of 20 years of follow-up N Engl J Med 332 1995 901 906
2. B. Fisher, P. Cardone, S.G. Economou 1-phenylalanine mustard (L-PAM) in the management of primary breast cancer A report of early findings N Engl J Med 292 1975 117 122
3. Early Breast Cancer Trialists' Collaborative Group Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy. 133 randomized trials involving 31,000 recurrences and 24,000 deaths among 75,000 women Lancet 339 1992 71 85
4. D.C. Tormey Adriamycin in breast cancer An overview of studies Cancer Chemother Rep 6 1975 319 327
5. H.T. Mouridsen Systemic therapy of advanced breast cancer Drugs 44 1992 17 28
6. French Epirubicin Study Group A prospective randomized phase III trial comparing combination chemotherapy with cyclophosphamide, fluorouracil and either doxorubicin or epirubicin J Clin Oncol 6 1988 679 688
7. J.L. Misset, M. di Palma, M. Delgado Adjuvant treatment of node-positive breast cancer with cyclophosphamide, doxorubicin, fluorouracil, and vincristine versus cyclophosphamide, methotrexate, and fluorouracil Final report after a 16-year median follow-up duration J Clin Oncol 14 1996 1136 1145
8. B. Fisher, C. Redmond, D.L. Wickerham Doxorubicin-containing regimens for the treatment of stage II breast cancer The National Surgical Adjuvant Breast and Bowel Project experience J Clin Oncol 7 1989 572 582
9. B. Fisher, A.M. Brown, N.V. Dimitrov Two months of doxorubicin- cyclophosphamide with and without interval reinduction therapy compared with 6 months of cyclophosphamide, methotrexate, and fluorouracil in positive-node breast cancer patients with tamoxifen-nonresponsive tumors Results from the National Surgical Adjuvant Breast and Bowel Project B-15 J Clin Oncol 8 1990 1483 1496
10. G. Bonadonna, M. Zambetti, P. Valagussa Sequential or alternating doxorubicin and CMF regimens in breast cancer with more than three positive nodes JAMA 273 1995 542 547
11. P. Fumoleau, V. Devaux, M.L. Vo Van The French Adjuvant Study Group Premenopausal patients with node-positive resectable breast cancer: Preliminary results of a randomised trial comparing 3 adjuvant regimens: FEC 50 × 6 cycles versus FEC 50 × 3 cycles versus FEC 75 × 3 cycles Drugs 45 1993 38 45
12. French Adjuvant Study Group Benefit of a high-dose epirubicin regimen in adjuvant chemotherapy for node-positive breast cancer patients with poor prognostic factors Five-year follow-up results of FASG 05 randomized trial J Clin Oncol 19 2001 602 611
13. P. Fumoleau, P. Kerbrat, P. Romestang Randomized trial comparing six versus three cycles of epirubicin-based adjuvant chemotherapy in premenauposal, node-positive breast cancer patients 10-year follow up results of the French Adjuvant Study Group 01 Trial J Clin Oncol 21 2003 298 305
14. R.F. Novak, C.H. Kharas Mitoxantrone Propensity for free radical formation and lipid peroxydation. Implication for cardiotoxicity Invest New Drugs 3 1985 95 96
15. J.D. Cowan, J. Neidhart, S. McClure Randomized trial of doxorubicin, bisantrene, and mitoxantrone in advanced breast cancer A South West Oncology Group Study J Nat Cancer Inst 83 1991 1077 1084
16. J.M. Bennett, H.B. Muss, J.H. Doroshow A randomized multicenter trial comparing mitoxantrone, cyclophosphamide, and fluorouracil with doxorubicin, cyclophosphamide, and fluorouracil in the therapy of metastatic breast cancer J Clin Oncol 6 1988 1611 1620
17. E.G. Mimmaugh, M.A. Trush, E. Ginsberg Differential effects of anthracycline drugs on rat heart and liver microsomial reduced nicotinamide adenine dinucleotide phosphate-dependent lipid peroxidation Cancer Res 42 1982 3574 3582
18. F.E. Durr Biologic and biochemical effects of mitoxantrone Semin Oncol 11 Suppl. 1 1984 3 10
19. T.D. Shenkenberg, D. Von Hoff Mitoxantrone A new anticancer drug with significant activity Ann Oncol 105 1986 67 81
20. R. Isacson, T. Safra, G.G. Ben-Dor A preliminary report of a pilot randomised trial comparing cyclophosphamide, methotrexate and 5-fluorouracil with cyclophosphamide, mitoxantrone and 5-fluorouracil in the adjuvant therapy of stage II breast cancer with four or more positive axillary nodes Anticancer Drugs 4 1993 189 192
21. A. Recht, S.E. Come, R.S. Gelman Integration of conservative surgery, radiotherapy and chemotherapy for the treatment of early-stage, node-positive breast cancer Sequencing, timing and outcome J Clin Oncol 9 1991 1662 1667
22. T.A. Buchholtz, M.A. Austin-Seymour, R.E. Moe Effect of delay in radiation in the combined modality treatment of breast cancer Int J Radiat Oncol Biol Phys 26 1993 23 35
23. B. Fisher, D.L. Wiskerham, M. Deutsch Breast tumor recurrence following lumpectomy with and without breast irradiation An overview of recent NSABP findings Sem Surg Oncol 8 1992 153 160
24. J.R. Harris, A. Recht Sequencing adjuvant chemotherapy and radiotherapy in breast cancer patients Int J Radiat Oncol Biol Phys 26 1993 183 185
25. P. Valagussa, M. Zambettei, S. Biasi Cardiac effects following adjuvant chemotherapy and breast irradiation in operable breast cancer Ann Oncol 5 1994 209 216
26. D. Serin, L. Aimard, S. Kirschers Chimiothérapie adjuvante FNC et radiothérapie concomitante dans les cancers du sein de stade II étude de faisabilité Bull Cancer 84 1997 247 253
27. J. Bonneterre, H. Roche, A. Bremond Results of randomized trial of adjuvant chemotherapy with FEC 50 vs FEC 100 in high risk node-positive breast cancer patients Proc Am Soc Clin Oncol 17 1998 A473
28. R.M. Meyer, G.P. Browman, M.L. Samosh Randomized phase II comparison of standard CHOP with weekly CHOP in elderly patients with non-Hodgkin's lymphoma J Clin Oncol 13 1995 2386 2393
29. E.L. Kaplan, P. Meier Nonparametric estimation from incomplete observations J Am Stat Assoc 53 1958 457 481
30. D.R. Cox Regression models and life-tables J R Stat Soc B 34 1972 187 202
31. A. Recht, S.E. Come, I.C. Henderson The sequencing of chemotherapy and radiation therapy after conservative surgery for early-stage breast cancer N Engl J Med 334 1996 1356 1361
32. J.R. Bellon, S.E. Come, R.S. Gelman Sequencing of chemotherapy and radiation therapy in early-stage breast cancer Updated results of a prospective randomized trial J Clin Oncol 23 2005 1934 1940
33. J. Huang, L. Barbera, M. Brouwers Does delay in starting treatment affect the outcomes of radiotherapy? A systematic review J Clin Oncol 21 2003 555 563
34. I.C. Henderson, D.A. Berry, G.D. Demetri Improved outcomes from adding sequential paclitaxel but not from escalating doxorubicin dose in an adjuvant chemotherapy regimen for patients with node-positive primary breast cancer J Clin Oncol 21 2003 976 983
35. C.I. Sartor, B.L. Peterson, S. Woolf Effect of addition of adjuvant paclitaxel on radiotherapy delivery and locoregional control of node-positive breast cancer Cancer and Leukemia Group B 9344 J Clin Oncol 23 2005 30 40
36. B. Fisher, J. Dignam, E.P. Mamounas Sequential methotrexate and fluorouracil for the treatment of node-negative breast cancer patients with estrogen receptor-negative tumors Eight-year results from National Surgical Adjuvant Breast and Bowel Project (NSABP) B-13 and first report of finding from NSABP B-19 comparing methotrexate and fluorouracil with conventional cyclophosphamide, methotrexate and fluorouracil J Clin Oncol 14 1996 1982 1992
37. G. Calais Radiation and concomitant chemotherapy after surgery for breast cancer Cancer Radiother 8 2004 39 47
38. G. Calais, D. Serin, A. Fourquet Randomized study comparing adjuvant radiotherapy (RT) with concomitant chemotherapy (CT) versus sequential treatment after conservative surgery for patients with stages I and II breast carcinoma [Abstract] Int J Radiat Oncol Biol Phys 54 Suppl. 2 2002 57
39. J.W. Denham, C.S. Hamilton, D. Christie Simultaneous adjuvant radiation therapy and chemotherapy in high-risk breast cancer-toxicity and dose modification A Trans-Tasman Radiation Oncology Group multi-institution study Int J Radiat Oncol Biol Phys 31 1995 305 313
40. G. Chaplain, C. Milan, C. Sgro Increased risk of acute leukaemia after adjuvant chemotherapy for breast cancer A population-based study J Clin Oncol 18 2000 2836 2842
41. M. Crump, T. Dongsheng, L. Shepherd Risk of acute leukemia following epirubicin-based adjuvant chemotherapy A report from the National Cancer Institute of Canada Clinical Trial Group J Clin Oncol 21 2003 3066 3071
42. Agence Française de Sécurité Sanitaire des Produits de Santé Bulletin de pharmacovigilance 1 2001 4
43. S.C. Formenti, M. Volm, K.A. Skinner Preoperative twice weekly paclitaxel with concurrent radiation therapy followed by surgery and postoperative doxorubicin-based chemotherapy in locally advanced breast cancer A phase I/II trial J Clin Oncol 21 2003 864 870
44. N. Ellerbroek, S. Martino, B. Mautner Breast-conserving therapy with adjuvant paclitaxel and radiation therapy Feasibility of concurrent treatment Breast J 9 2003 74 78
45. Y.M. Hanna, K.L. Baglan, J.S. Stromberg Acute and subacute toxicity associated with concurrent adjuvant radiation therapy and paclitaxel in primary breast cancer therapy Breast J 8 2002 149 153
46. A.G. Taghian, S.I. Assaad, A. Niemierko Risk of pneumonitis in breast cancer patients treated with radiation therapy and combination chemotherapy with paclitaxel J Natl Cancer Inst 93 2001 1806 1811
47. J.R. Bellon, K.L. Lindsley, G.K. Ellis Concurrent radiation therapy and paclitaxel or docetaxel chemotherapy in high-risk breast cancer Int J Radiat Oncol Biol Phys 48 2000 393 397